Found: 6
Select item for more details and to access through your institution.
Pharmacokinetics and Pharmacodynamics of the Non-Nucleoside Reverse-Transcriptase Inhibitor Etravirine in Treatment-Experienced HIV-1-Infected Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2010, v. 88, n. 5, p. 695, doi. 10.1038/clpt.2010.181
- By:
- Publication type:
- Article
Safety and pharmacokinetics of etravirine in pregnant HIV-1-infected women.
- Published in:
- HIV Medicine, 2011, v. 12, n. 4, p. 257, doi. 10.1111/j.1468-1293.2010.00874.x
- By:
- Publication type:
- Article
Assessment of the steady-state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers.
- Published in:
- HIV Medicine, 2009, v. 10, n. 3, p. 173, doi. 10.1111/j.1468-1293.2008.00668.x
- By:
- Publication type:
- Article
Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 6, p. 631, doi. 10.1111/jvh.12853
- By:
- Publication type:
- Article
Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease.
- Published in:
- Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 287, doi. 10.1111/jvh.12645
- By:
- Publication type:
- Article
Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naïve, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227.
- Published in:
- HIV Medicine, 2008, v. 9, n. 10, p. 883, doi. 10.1111/j.1468-1293.2008.00644.x
- By:
- Publication type:
- Article